EUVIMEDEUVIMED entdecken
Kohortenstudie

Seroprevalence of lyme borreliosis among patients with arthritis and arthralgia at a tertiary care center: a prospective cohort study

Gamze Helvacı iD, Özlem Oya Eren-Kutsoylu, Elif Alaçam iD, Banu Kasapoğlu, Gökçe Kenar Artin, Ayca Arzu Sayıner, Vildan Avkan-Oguz

European Journal of Clinical Microbiology & Infectious Diseases · 14.11.2026

DOI: 10.1007/s10096-026-05643-w ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 14.11.2026. Verfasst von Gamze Helvacı und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Dokuz Eylül University, Izmir, Türkiye. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Dokuz Eylül Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although arthritis is a known late symptom in Lyme borreliosis, joint pain is non-specific and can lead to unnecessary serological testing. This study aimed to determine the seroprevalence of anti-Borrelia IgG antibodies in patients presenting with joint pain and/or arthritis at a tertiary care center in Izmir, Türkiye, and to evaluate whether routine serological screening is necessary in this population.

Methods

This prospective cohort study included adults presenting with arthralgia and/or arthritis between January 2024 and January 2025. Demographic characteristics, clinical findings, and potential epidemiological exposures were recorded through face-to-face interviews. Serum anti- Borrelia IgG antibodies were initially screened using an enzyme-linked fluorescent assay(ELFA; VIDAS Lyme IgG, bioMérieux, France). Samples with positive ELFA results were subsequently evaluated using an IgG immunoblot assay containing antigens from multiple members of the Borrelia burgdorferi sensu lato complex(EUROLINE Anti-Borrelia IgG, Euroimmun, Germany).

Results

Overall, 601 patients were enrolled; all presented with arthralgia, and 80 exhibited clinically objective arthritis. Five patients (0.8%) screened positive by ELFA, with two confirmed via immunoblotting, yielding a confirmed seroprevalence of 0.3% (2/601). Confirmed seropositivity was identified in one patient with arthritis (1.25%; 1/80) and one with isolated arthralgia(0.19%; 1/521). Neither confirmed individual reported tick exposure or a history of erythema migrans. Integrating epidemiological, clinical, and laboratory parameters, a definitive diagnosis of LB was ruled out for all subjects.

Conclusions

Immunoblot-confirmed anti- Borrelia IgG seroprevalence is exceedingly low among patients with joint symptoms in İzmir. Consequently, routine LB screening is discouraged for nonspecific arthralgia or arthritis without strong epidemiological and clinical indicators. Serological findings must always be contextualized clinically, and regional assay validation is recommended to optimize diagnostic accuracy.

Schlagwörter

Stichwörter der Autor:innen

ArthralgiaArthritisBorrelia burgdorferi sensu latoImmunoblotLyme borreliosisSeroprevalence

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Dokuz Eylül University, Izmir, Türkiye.
  • Faculty of Medicine, Department of Medical Microbiology, Dokuz Eylül University, Izmir, Türkiye.
  • Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Dokuz Eylül University, Izmir, Türkiye.
  • Faculty of Medicine, Department of Rheumatology, Dokuz Eylül University, Izmir, Türkiye.
  • Faculty of Medicine, Department of Medical Microbiology, Dokuz Eylül University, Izmir, Türkiye. arzu.sayiner@deu.edu.tr.
  • Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Dokuz Eylül University, Izmir, Türkiye. vildan.oguz@deu.edu.tr.

ORCID-Profile: Gamze Helvacı, Elif Alaçam

Förderung

  • Dokuz Eylül Üniversitesi

Zitieren

APA

Helvacı, G., Eren-Kutsoylu, Ö. O., Alaçam, E., Kasapoğlu, B., Artin, G. K., Sayıner, A. A., & Avkan-Oguz, V. (2026). Seroprevalence of lyme borreliosis among patients with arthritis and arthralgia at a tertiary care center: a prospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-026-05643-w

Vancouver

Helvacı G, Eren-Kutsoylu ÖO, Alaçam E, Kasapoğlu B, Artin GK, Sayıner AA, et al. Seroprevalence of lyme borreliosis among patients with arthritis and arthralgia at a tertiary care center: a prospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 2026. doi:10.1007/s10096-026-05643-w

BibTeX
@article{Helvac2026,
  author = {Helvacı, Gamze and Eren-Kutsoylu, Özlem Oya and Alaçam, Elif and Kasapoğlu, Banu and Artin, Gökçe Kenar and Sayıner, Ayca Arzu and Avkan-Oguz, Vildan},
  title = {Seroprevalence of lyme borreliosis among patients with arthritis and arthralgia at a tertiary care center: a prospective cohort study},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2026},
  doi = {10.1007/s10096-026-05643-w}
}
Kostenlos starten →